Читать книгу Veterinary Surgical Oncology - Группа авторов - Страница 75

Tracheobronchial stenosis secondary to neoplasia can result in severe and often life‐threatening clinical signs in human and veterinary patients. When possible, resection of the stenotic region should be attempted (Shin et al. 2006; Withrow 2007). Neoplastic disease may be extensive, however, precluding the successful use of surgery. Intraluminal tracheobronchial stenting has developed as a treatment option in cases where surgery is not recommended or not elected by human patients (Lee 2000; Husain et al. 2007; Kim et al. 2009).

Intraluminal tracheal stenting has been well described in veterinary medicine for the treatment of tracheal collapse (Moritz et al. 2004; Sura and Krahwinkel 2008). Currently, only one case of intraluminal tracheal stenting to treat tracheal neoplasia has been documented in the veterinary literature (Culp et al. 2007). In that cat, a 2.6 cm long tracheal carcinoma was diagnosed, and the owners elected to perform intraluminal tracheal stenting to palliate the clinical signs. The clinical signs were relieved for a period of six weeks until metastatic disease was noted in the pulmonary parenchyma and the owners elected euthanasia. No complications associated with the intraluminal tracheal stenting procedure or postprocedure were noted, although a necropsy was not performed (Culp et al. 2007).